Targeted nitroxide agents

US10526368B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10526368-B2
Application numberUS-201715855598-A
CountryUS
Kind codeB2
Filing dateDec 27, 2017
Priority dateJul 17, 2008
Publication dateJan 7, 2020
Grant dateJan 7, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by radiation. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation.

First claim

Opening claim text (preview).

We claim: 1. A compound having the structure: wherein X is R 1 is isobutyl; R 2 is hydrogen R 4 is hydrogen, R 3 is —NH—R 5 , and R 5 is and; R is —P(O)(Ph) 2 .

Assignees

Inventors

Classifications

  • Free radical scavengers or antioxidants · CPC title

  • Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00) · CPC title

  • Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65) · CPC title

  • attached in position 4 · CPC title

  • Bridged systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10526368B2 cover?
Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by rad…
Who is the assignee on this patent?
Univ Of Pittsburgh—Of The Commonwealth System Of Higher Education
What technology area does this patent fall under?
Primary CPC classification C07K5/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).